| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Medical Officer and EVP
1 company
Michele Trucksis last filed a Form 4 in January 2018, as See Remarks at MCRB. Michele Trucksis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 4,893 shares of MCRB. The MCRB filings lean toward selling, a net 44,827 shares.
Michele Trucksis has 5 Form 4 filings on record from February 2016 to January 2018, all as Seres Therapeutics (MCRB), 2016–2018.
The 10 reported transactions were 4 option or other derivative awards, 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.5M.
The largest open-market sale was 38,064 shares of MCRB at an average $35.14 on July 27, 2016, about $1.3M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 2,607 | $11.02 | $28,729.14 | -34.8% | |
| Jul 28, 2016 | MCRB Seres Therapeutics, Inc. | Chief Medical Officer and EVP | Sale+OE | 4,156 | $35.18 | $146,207.25 | - | |
| Jul 27, 2016 | MCRB Seres Therapeutics, Inc. | Chief Medical Officer and EVP | Sale+OE | 38,064 | $35.14 | $1,337,511.86 | - |